Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04385953 · ClinicalTrials.gov registry record

QStat in Trauma and Obstetric Hemorrhage

A clinical trial of Trauma and Post Partum Hemorrhage, sponsored by HemoSonics.

Completed
Registry status
22
Enrollment target
1
Study location

NCT04385953 is a study of Trauma and Post Partum Hemorrhage that has completed, run by HemoSonics. The registered enrollment target is 22 participants, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04385953, a study of Trauma and Post Partum Hemorrhage, has completed, sponsored by HemoSonics.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QStat Cartridge in trauma patients and obstetric patients with postpartum hemorrhage.

Interventions

  • DIAGNOSTIC_TEST Quantra System

Study Locations (1)

California

  • Zuckerberg San Francisco General Hospital and Trauma Center - San Francisco

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2019-12-10
Est. Completion 2020-08-01

Sponsor

HemoSonics

24 total trials

What the Registry Record Tells You About NCT04385953

The ClinicalTrials.gov registry entry for NCT04385953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (93% lower). The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which Quantra System is the first listed.

NCT04385953 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04385953 about?

NCT04385953 is a clinical study titled "QStat in Trauma and Obstetric Hemorrhage". This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QStat Cartridge in trauma patients and obstetric patients with postpartum hemorrhage.

What is the current status of trial NCT04385953?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2019-12-10. Estimated completion is 2020-08-01.

What conditions does trial NCT04385953 study?

This clinical trial studies the following conditions: Trauma, Post Partum Hemorrhage, Blood Loss Massive.

What interventions are being tested in trial NCT04385953?

The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04385953?

This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04385953 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.